4
Changes in Ownership
Calidi Biotherapeutics, Inc. Filed Acc 0001641172-25-025445
Chief Financial Officer bought 2,500 shares at $2.00 ($5,000)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jackson Andrew C. Chief Financial Officer | 2025-08-21 | Purchase | +2,500 | $2.00 | $5,000 | 2,500 | D |
| Derivatives | |||||||
| Jackson Andrew C. Chief Financial Officer | 2025-08-21 | Purchase · Warrant (right to buy) | +2,500 | 2,500 | D | ||
| Open-market purchases · 2,500 sh · avg $2.00 · $5,000 | |||||||
Loading xslF345X05/ownership.xml…